Article
The Disruption of SARS-CoV-2 RBD/ACE-2 Complex By Ubrogepant is Mediated By Interface…
Preprints · 2023 · I.O. Omotuyi, author O. Nash, author B.O. Ajiboye, author D.S. Metibemu, author B.E. Oyinloye, author AA Ojo, author K Okaiyeto, author
Key facts
| Title | The Disruption of SARS-CoV-2 RBD/ACE-2 Complex By Ubrogepant is Mediated By Interface Hydration |
|---|---|
| First author | I.O. Omotuyi, author O. Nash, author B.O. Ajiboye, author D.S. Metibemu, author B.E. Oyinloye, author AA Ojo, author K Okaiyeto, author |
| Journal | Preprints |
| Published | Aug 1, 2023 |
| DOI | 10.20944/preprints202003.0466.v1 |
| Devices mentioned | 000004 |
At a glance
- 1–9 FDA submissions mentioned
- None Product codes mentioned
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About Literature
Peer-reviewed and preprint literature indexed by Orca1 and linked to the FDA submissions and product codes each article mentions. Only bibliographic details are shown here.
Source: Publisher and PubMed metadata; device mentions identified by Orca1